1. Home
  2. TYRA vs BLBD Comparison

TYRA vs BLBD Comparison

Compare TYRA & BLBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tyra Biosciences Inc.

TYRA

Tyra Biosciences Inc.

HOLD

Current Price

$32.81

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Logo Blue Bird Corporation

BLBD

Blue Bird Corporation

HOLD

Current Price

$77.50

Market Cap

2.3B

ML Signal

HOLD

Company Overview

Basic Information
Metric
TYRA
BLBD
Founded
2018
1927
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Construction/Ag Equipment/Trucks
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.3B
IPO Year
2021
2013

Fundamental Metrics

Financial Performance
Metric
TYRA
BLBD
Price
$32.81
$77.50
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
11
6
Target Price
$47.50
$68.00
AVG Volume (30 Days)
988.1K
424.6K
Earning Date
05-06-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
22.78
EPS
N/A
1.84
Revenue
N/A
$1,480,099,000.00
Revenue This Year
N/A
$5.87
Revenue Next Year
N/A
$6.83
P/E Ratio
N/A
$42.48
Revenue Growth
N/A
9.87
52 Week Low
$9.96
$42.00
52 Week High
$40.65
$81.51

Technical Indicators

Market Signals
Indicator
TYRA
BLBD
Relative Strength Index (RSI) 59.71 57.69
Support Level $29.68 $48.63
Resistance Level $33.99 $81.07
Average True Range (ATR) 1.84 2.91
MACD 0.47 -0.16
Stochastic Oscillator 93.67 60.39

Price Performance

Historical Comparison
TYRA
BLBD

About TYRA Tyra Biosciences Inc.

Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines for large opportunities in targeted oncology and genetically defined conditions, harnessing the power of Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are FGFR3, FGFR4/3, and FGFR1/2/3: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.

About BLBD Blue Bird Corporation

Blue Bird Corp is an American bus manufacturing company. It is an independent designer and manufacturer of school buses. The company operates in two segments; the Bus segment which involves the design, engineering, manufacture, and sales of school buses and extended warranties; and the Parts segment which includes the sales of replacement bus parts. Geographically, the company generates a majority of its revenue from its customers in the United States and the rest from Canada and Rest of the world.

Share on Social Networks: